Dr Michael Baker speaks with JustStocks about $20 million funding milestone

MediaAll
Written By Michelle Long

Arovella Therapeutics CEO, Dr Michael Baker, spoke with JustStocks Video about the company’s recent $20 million capital raise, a major milestone that sets the stage for its ambitious clinical goals.

View the ASX release announcing Arovella’s $20 million Placement.

 
Michelle Long
Next

Arovella fully funded to complete phase 1 with $20m placement